About Senda Biosciences
Senda Biosciences, Inc. is uniquely positioned to transform human health by harnessing millions of years of evolution to program targeted, potent and tunable medicines. Nature has provided the codes to program human cells – both from within (mRNA) and from outside – from what surrounds them. The trillions of non-human cells in the human ecosystem have evolved natural nanoparticles that precisely shuttle biomolecules into human cells, providing the missing pieces to fully unlock programmable medicines. Senda’s proprietary platform includes the first-ever atlas of nature-derived programmable systems at the molecular level and across all kingdoms of life – accessing the entire code provided by nature required to program cells. With this platform, Senda is developing a new class of SendRNA™ medicines. The unique properties of these medicines create new frontiers for mRNA therapeutics and vaccines for infectious, genetic, autoimmune, and metabolic diseases and oncology indications – with further potential to transform the gene editing and protein-based therapy landscapes as well. Based in Cambridge, MA, Senda was founded by Flagship Pioneering. For more information, visit sendabiosciences.com or follow us on Twitter and LinkedIn.
Responsibilities
- Perform competitive intelligence and analysis in the Pharmaceutical and Biotechnology industries, including mapping of drug modalities, therapeutic areas, and deals
- Work closely with the executive team (e.g., head of strategy) and external experts to build and prioritize Senda’s pipeline
- Work closely with the strategy team for creating investor decks and playing an integral role in crafting Senda’s message to investors
- Work closely with the BD team for shaping deals with major pharma / biotech companies across multiple therapeutic areas and indications
- Work closely with the strategy team for analyses of potential value pools to inform Senda’s strategy and guide our internal prioritization
- Support corporate activities to include deal sourcing, due diligence, execution, and integration
- Hours – Must be 40 hours per week
Qualifications
- Master’s degree students interested in a Co-op for the Fall term (July-December 2023)
- Enrolled in the (Choose)
- College of Engineering (Biochemical, Bioengineering, or Biomedical Engineering majors)
- College of Science (Biology, Cell and Molecular Biology, Chemistry undergrad majors) and (Biotechnology, Biotechnology experiential, Bioinformatics, Chemistry in Master’s degree)
- College of Health Sciences (Biomedical Science, Pharmaceutics and Drug Delivery, Pharmacology majors in Master’s degrees)
- Candidates must have a GPA of 3.5 or higher
- Preference is for co-ops who have already completed their first co-op
Senda Biosciences is an Equal Opportunity Employer. Senda does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, national origin, veteran status, or any other status protected under federal, state, or local law.
